Doximity Total Current Liabilities 2020-2025 | DOCS
Doximity total current liabilities from 2020 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- Doximity total current liabilities for the quarter ending March 31, 2025 were $0.156B, a 6.12% increase year-over-year.
- Doximity total current liabilities for 2025 were $0.156B, a 6.12% increase from 2024.
- Doximity total current liabilities for 2024 were $0.147B, a 5.55% increase from 2023.
- Doximity total current liabilities for 2023 were $0.14B, a 25.36% increase from 2022.
| Doximity Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025 | $156 |
| 2024 | $147 |
| 2023 | $140 |
| 2022 | $111 |
| 2021 | $102 |
| 2020 | $56 |
| 2019 | $0 |
| Doximity Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $156 |
| 2024-12-31 | $116 |
| 2024-09-30 | $132 |
| 2024-06-30 | $135 |
| 2024-03-31 | $147 |
| 2023-12-31 | $105 |
| 2023-09-30 | $123 |
| 2023-06-30 | $133 |
| 2023-03-31 | $140 |
| 2022-12-31 | $106 |
| 2022-09-30 | $118 |
| 2022-06-30 | $121 |
| 2022-03-31 | $111 |
| 2021-12-31 | $92 |
| 2021-09-30 | $96 |
| 2021-06-30 | $100 |
| 2021-03-31 | $102 |
| 2020-12-31 | $102 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | $56 |
| 2019-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.290B | $0.570B |
| Doximity Inc. provides digital platform for medical professionals. The company's network members include physicians across all specialties and practice areas. It provide its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and conduct virtual patient visits. Doximity Inc. is based in SAN FRANCISCO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.130B | 58.69 |
| Hims & Hers Health (HIMS) | United States | $11.277B | 117.16 |
| Tempus AI (TEM) | United States | $10.557B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.350B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.741B | 58.45 |
| Hinge Health (HNGE) | United States | $3.664B | 0.00 |
| Privia Health (PRVA) | United States | $2.391B | 163.42 |
| Schrodinger (SDGR) | United States | $1.574B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.37 |
| Clover Health Investments (CLOV) | United States | $1.496B | 0.00 |
| 10x Genomics (TXG) | United States | $1.496B | 0.00 |
| Azenta (AZTA) | United States | $1.427B | 66.30 |
| Omnicell (OMCL) | United States | $1.259B | 22.22 |
| Evolent Health (EVH) | United States | $1.119B | 95.30 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.541B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.415B | 124.00 |
| TruBridge (TBRG) | United States | $0.336B | 746.33 |
| Outset Medical (OM) | United States | $0.309B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.280B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| CapsoVision (CV) | United States | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.155B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.85 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |